Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Gypsy-Rose Blanchard exclusively told PEOPLE that she is not using weight-loss drugs to lose weight since giving birth to her ...
Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
International Community Health Services (ICHS) has launched Together We Rise, a wellness podcast with useful information ...
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback